Literature DB >> 19214161

Update: influenza activity - United States, September 28, 2008--January 31, 2009.

.   

Abstract

From September 28, 2008, to January 31, 2009, influenza activity remained low in the United States but began to increase at the end of January. Thus far during the 2008-09 influenza season, influenza A viruses have predominated and are antigenically related to the 2008-09 influenza vaccine strains. Oseltamivir resistance has been detected in nearly all of the influenza A (H1N1) viruses tested so far during the 2008-09 season, with high levels of adamantane resistance among influenza A (H3N2) viruses. This report summarizes U.S. influenza activity since the last update and reviews interim recommendations for the use of influenza antiviral medications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19214161

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  12 in total

1.  Generation and characterization of recombinant pandemic influenza A(H1N1) viruses resistant to neuraminidase inhibitors.

Authors:  Andrés Pizzorno; Xavier Bouhy; Yacine Abed; Guy Boivin
Journal:  J Infect Dis       Date:  2011-01-01       Impact factor: 5.226

2.  Unique Determinants of Neuraminidase Inhibitor Resistance among N3, N7, and N9 Avian Influenza Viruses.

Authors:  Min-Suk Song; Bindumadhav M Marathe; Gyanendra Kumar; Sook-San Wong; Adam Rubrum; Mark Zanin; Young-Ki Choi; Robert G Webster; Elena A Govorkova; Richard J Webby
Journal:  J Virol       Date:  2015-08-19       Impact factor: 5.103

3.  Echinacea purpurea aerial extract alters course of influenza infection in mice.

Authors:  Dahlene Fusco; Xinyan Liu; Caroline Savage; Ying Taur; Weilie Xiao; Edward Kennelly; Jianda Yuan; Barrie Cassileth; Mirella Salvatore; Genovefa A Papanicolaou
Journal:  Vaccine       Date:  2010-04-09       Impact factor: 3.641

4.  Susceptibility of human H3N2 influenza virus to oseltamivir in South Korea, 2009-2011.

Authors:  Sehee Park; Jin Il Kim; Ilseob Lee; Sangmoo Lee; Min-Woong Hwang; Joon-Yong Bae; Jun Heo; Eun-Joo Lim; Won-Seok Seok; Hee Jin Cheong; Joon Young Song; Woo Joo Kim; Man-Seong Park
Journal:  J Microbiol       Date:  2012-12-30       Impact factor: 3.422

5.  Evidence of person-to-person transmission of oseltamivir-resistant pandemic influenza A(H1N1) 2009 virus in a hematology unit.

Authors:  Catherine Moore; Monica Galiano; Angie Lackenby; Tamer Abdelrahman; Rosemary Barnes; Meirion R Evans; Christopher Fegan; Susannah Froude; Mark Hastings; Steven Knapper; Emma Litt; Nicola Price; Roland Salmon; Mark Temple; Eleri Davies
Journal:  J Infect Dis       Date:  2011-01-01       Impact factor: 5.226

6.  Sequence-Specific Modifications Enhance the Broad-Spectrum Antiviral Response Activated by RIG-I Agonists.

Authors:  Cindy Chiang; Vladimir Beljanski; Kevin Yin; David Olagnier; Fethia Ben Yebdri; Courtney Steel; Marie-Line Goulet; Victor R DeFilippis; Daniel N Streblow; Elias K Haddad; Lydie Trautmann; Ted Ross; Rongtuan Lin; John Hiscott
Journal:  J Virol       Date:  2015-05-27       Impact factor: 5.103

7.  Pandemic influenza: implications for programs controlling for HIV infection, tuberculosis, and chronic viral hepatitis.

Authors:  James D Heffelfinger; Pragna Patel; John T Brooks; Helene Calvet; Charles L Daley; Hazel D Dean; Brian R Edlin; Kathleen F Gensheimer; John Jereb; Charlotte K Kent; Jeffrey L Lennox; Janice K Louie; Ruth Lynfield; Philip J Peters; Lauretta Pinckney; Philip Spradling; Andrew C Voetsch; Anthony Fiore
Journal:  Am J Public Health       Date:  2009-10       Impact factor: 9.308

8.  Neuraminidase inhibitor susceptibility testing in human influenza viruses: a laboratory surveillance perspective.

Authors:  Margaret Okomo-Adhiambo; Katrina Sleeman; Kristina Ballenger; Ha T Nguyen; Vasiliy P Mishin; Tiffany G Sheu; James Smagala; Yan Li; Alexander I Klimov; Larisa V Gubareva
Journal:  Viruses       Date:  2010-10-13       Impact factor: 5.818

9.  Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010-11.

Authors:  Aaron D Storms; Larisa V Gubareva; Su Su; John T Wheeling; Margaret Okomo-Adhiambo; Chao-Yang Pan; Erik Reisdorf; Kirsten St George; Robert Myers; Jason T Wotton; Sara Robinson; Brandon Leader; Martha Thompson; Marjorie Shannon; Alexander Klimov; Alicia M Fry
Journal:  Emerg Infect Dis       Date:  2012-02       Impact factor: 6.883

10.  The novel influenza A (H1N1) virus pandemic: An update.

Authors:  N Petrosillo; S Di Bella; C M Drapeau; E Grilli
Journal:  Ann Thorac Med       Date:  2009-10       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.